« Providers

Kentucky Medicaid

Medical Policies

Medical policies offer guidance on determination of medical necessity and appropriateness of care for approved benefits. Benefit determinations and coverage decisions are subject to all the terms and conditions of Humana – CareSource® including eligibility, definitions, specific inclusions or exclusions, and applicable state or federal laws.

The medical policies do not constitute medical advice or medical care. Treating health care providers are solely responsible for diagnosis, treatment and medical advice. Humana – CareSource is not responsible for, does not provide, and does not represent itself as a provider of medical care.

Policies are considered guidelines and are not intended to infer benefits or coverage for a specific member. Benefit determinations are based on the specific facts of each member’s case. If a service or supply is not eligible for coverage, a member and the treating provider may proceed with that service or supply after receiving a denial from Humana – CareSource for the requested non-covered service.

Existing clinical policies are regularly reviewed and updated. New policies are added as appropriate while previous versions are maintained in the policy archive. These policy changes are maintained on this site.

The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.

Current Medical Policies

PolicyEffective Date
17 Alpha Hydroxyprogesterone caproate (Makena)
Acute In-Patient Detoxification (Opioid) Prior Authorization Criteria
Alpha-1 Proteinase Inhibitors
Applied Behavior Analysis (ABA) Therapy
Autoimmune Diseases Biologic Therapies
Benlysta (Belimumab)
Biologic Cholesterol Agents
Biologic and other Ophthalmologic Agents
Botulinum Toxin Injection
Colony Stimulating Factors
Cystic Fibrosis
Cytomegalovirus Immune Globulin Intravenous (Cytogam)
Dispense as Written (DAW) Requests
Enzyme Replacement Therapy
Exondys 51
Hematopoietic Growth Factors
Hemophilic Agents
Hepatitis C - Oral
Hereditary Angioedema and Pharmacotherapy
Home Infusion Therapy
Hyaluronic Acid Derivative Injection
Idiopathic Pulmonary Fibrosis: Esbriet (Pirfenidone), OFEV (Nintedanib)
Immune (Idiopathic) Thrombocytopenia Purpura (ITP)
Immune Globulin (IVIG, IGIV, or IMIG or SCIG)
Inflammatory Bowel Disease: Biological Therapies
Insulin Infusion Pump Therapy for Diabetes
Lupron DEPOT
Medication Assisted Therapy: Buprenorphine-Naloxone sublingual tablets (Formulary Statement)
Medication Assisted Therapy (MAT): Suboxone
Multiple Sclerosis Therapy Class
Palivizumab (Synagis)
Parenteral Calcium Regulators - pamidronate (Aredia), zoledronic acid (Reclast and Zometa), ibandronate (Boniva), denosumab (Prolia and Xgeva), teriparatide (Forteo)
Pegylated and Non-Pegylated Interferon
Proton Pump Inhibitors (Formulary Statement)
Psoriasis: Biological Therapies
Pulmonary Arterial Hypertension
Rituxan (rituximab)
Seizure Disorders (Repository Corticotropin Injection (H.P. Acthar Gel) and Vigabatrin (Sabril) Oral Solution and Tablets)
Serum Biomarker Panel Testing in Systemic Lupus Erythematosus and Rheumatoid Arthritis
Short Bowel Syndrome (Gattex, Zorbtive)

Archived Medical Policies